Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target
- PMID: 1517576
Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target
Abstract
Inflammatory mouse peritoneal macrophages were activated by IFN-gamma in synergy with IL-2 or Lipid A to mediate TNF production for autocrine generation of cytotoxic nitric oxide (NO) to kill P815 or L1210 tumor targets. It was determined that for IL-2, but not Lipid A, to effectively trigger activation of IFN-gamma-primed macrophages, the tumor targets must be also present for interaction with effector macrophages to mediate the production of TNF and NO. IFN-gamma- and IL-2-activated macrophages from syngeneic DBA/2 and allogeneic C3H mice had identical MHC-unrestricted requirements for interaction with DBA/2 mouse-derived P815 and L1210 targets to mediate production of TNF and NO for tumor cytotoxicity. To further define the mechanistic requirements for macrophage-tumor target interaction, IFN-gamma- and IL-2-activated macrophages were separated from P815 targets in culture by a semipermeable membrane. Under these conditions, both TNF and NO were produced by the macrophage, which indicated that the requirement for tumor target-macrophage interaction may be due to a soluble factor produced by the target rather than to direct physical contact. This was confirmed by experiments in which 24-h cell-free culture fluids, derived from either P815 or L1210 tumor targets, substituted for the intact tumor cells in the stimulation of TNF mRNA synthesis and secretion with NO generation of TNF mRNA synthesis and secretion with NO generation by IFN-gamma- and IL-2-activated C3H or DBA/2 macrophages. The activity in 24-h culture fluids derived from P815 and L1210 tumor targets was tentatively designated as tumor-derived recognition factor(s) (TDRF) since it was produced constitutively by the tumor targets and synergized with IFN-gamma and IL-2 to induce macrophage production of TNF and NO for death of the same targets. A variety of nontransformed human and mouse fibroblasts, mouse spleen lymphocytes, and two adherent mouse fibrosarcomas did not produce detectable TDRF activity, whereas two mouse T lymphomas, EL4 and EL4.IL-2, produced TDRF activity similar to L1210 mouse leukemia and P815 mastocytoma. The C3H/MCA, a TDRF-nonproducing mouse fibrosarcoma, was susceptible to cytotoxicity mediated by macrophages activated by IFN-gamma and Lipid A, but not by IL-2 triggering. Exogenous TDRF derived from L1210 targets reconstituted the cytotoxic activity for C3H/MCA MCA targets mediated by IFN-gamma- and IL-2-activated macrophages accompanied by the production of TNF and cytotoxic NO.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.J Immunol. 1991 Sep 15;147(6):1816-22. J Immunol. 1991. PMID: 1909732
-
Tumor-derived recognition factor (TDRF) induces production of TNF-alpha by murine macrophages, but requires synergy with IFN-gamma alone or in combination with IL-2 to induce nitric oxide synthase.Int J Immunopharmacol. 1996 Aug-Sep;18(8-9):479-90. doi: 10.1016/s0192-0561(96)00053-7. Int J Immunopharmacol. 1996. PMID: 9023587
-
Mechanistic differences between migration inhibitory factor (MIF) and IFN-gamma for macrophage activation. MIF and IFN-gamma synergize with lipid A to mediate migration inhibition but only IFN-gamma induces production of TNF-alpha and nitric oxide.J Immunol. 1993 May 15;150(10):4524-31. J Immunol. 1993. PMID: 7683323
-
Cytokine-induced macrophage differentiation: a tale of 2 genes.Clin Invest Med. 1999 Dec;22(6):236-55. Clin Invest Med. 1999. PMID: 10664866 Review.
-
Tumor necrosis factor-alpha: central regulatory cytokine in the induction of macrophage antimicrobial activities.Pathobiology. 1991;59(3):182-4. doi: 10.1159/000163640. Pathobiology. 1991. PMID: 1909141 Review.
Cited by
-
KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation.Int J Cancer. 2018 Oct 15;143(8):1994-2007. doi: 10.1002/ijc.31592. Epub 2018 Aug 9. Int J Cancer. 2018. PMID: 29756386 Free PMC article.
-
Macrophages produce nitric oxide at allograft sites.Ann Surg. 1993 Aug;218(2):159-66. doi: 10.1097/00000658-199308000-00007. Ann Surg. 1993. PMID: 8342995 Free PMC article.
-
Nitric Oxide in Macrophage Immunometabolism: Hiding in Plain Sight.Metabolites. 2020 Oct 26;10(11):429. doi: 10.3390/metabo10110429. Metabolites. 2020. PMID: 33114647 Free PMC article. Review.
-
The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.Biochem Pharmacol. 2018 Mar;149:205-223. doi: 10.1016/j.bcp.2018.01.042. Epub 2018 Feb 14. Biochem Pharmacol. 2018. PMID: 29397935 Free PMC article. Review.
-
Tumour necrosis factor alpha is elevated in serum and cerebrospinal fluid in multiple sclerosis and inflammatory neuropathies.J Neurol. 1996 Feb;243(2):165-70. doi: 10.1007/BF02444010. J Neurol. 1996. PMID: 8750556
MeSH terms
Substances
LinkOut - more resources
Research Materials